Gapping down
In reaction to disappointing earnings/guidance:
- PBPB -28.2%, INGN -28%, TWOU -18.7%, NVTA -17.2%, DDD -16.1%, SUPN -13.4%, LTHM -11.6%, PLUG -11.3%, AERI -8.2%, TRIP -7.2%, ICHR -7.1%, FARM -6.6% (ticking lower; also announces departure of CEO Michael Keown; appoints Christopher P. Mottern as Interim CEO, effective immediately), MGI -6.6%, CHK -6.5%, OPK -5.9%, HCLP -4.7%, WU -4.7%, ACLS -4.6%, ZAGG -4.5%, MCHP -4.4%, OSPN -4.3%, COTY -4.1%, MYGN -3.9%, HUBS -3.6%, UUUU -3.1%, HMC -3.1%, LYFT -2.5%, S -2.4%, MPLX -2.2%, MPC -1.9%, OSW -1.9%, STWD -1.9%, KAR -1.8%, LADR -1.8%, CRAY -1.7%, MMI -1.7%, HALO -1.4%, PEGA -1.3%, HZNP -1.3%, ZYNE -1.3%
Other news:
- RGNX -2.5% (ticking lower after reporting additional interim Phase 1/2a trial update for RGX-314 for the treatment of wet age-related macular degeneration)
- DWDP -0.5% (DowDuPont Board approves separation of Agriculture Division, which will become Corteva Agriscience on June 1, 2019)
Analyst comments:
- X -4% (downgraded to Sell from Neutral at UBS)
- GSKY -2% (downgraded to Neutral from Buy at Guggenheim)